SKLB188 inhibits the growth of head and neck squamous cell carcinoma by suppressing EGFR signalling

被引：0
|
作者：
Mansoureh Barzegar
Shuang Ma
Chao Zhang
Xin Chen
Ying Gu
Chaowei Shang
Xiaojuan Jiang
Jiao Yang
Cherie-Ann Nathan
Shengyong Yang
Shile Huang
机构：
[1] Louisiana State University Health Sciences Center,Department of Biochemistry and Molecular Biology
[2] 1501 Kings Highway,Department of Otolaryngology
[3] Shreveport,Head and Neck Surgery
[4] LA 71130-3932,undefined
[5] USA,undefined
[6] State Key Laboratory of Biotherapy and Cancer Center/Collaborative Innovation Center of Biotherapy,undefined
[7] West China Hospital,undefined
[8] West China Medical School,undefined
[9] Sichuan University,undefined
[10] Feist-Weiller Cancer Center,undefined
[11] Louisiana State University Health Sciences Center,undefined
[12] Louisiana State University Health Sciences Center,undefined
来源：
British Journal of Cancer | 2017年 / 117卷
关键词：
SKLB188; head and neck cancer; cell proliferation; apoptosis; EGF receptor; Erk1/2; Akt;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1154 / 1163
页数：9
相关论文
共 50 条
  • [21] Honokiol inhibits the growth of head and neck squamous cell carcinoma by targeting epidermal growth factor receptor
    Singh, Tripti
    Gupta, Nirzari A.
    Xu, Su
    Prasad, Ram
    Velu, Sadanandan E.
    Katiyar, Santosh K.
    ONCOTARGET, 2015, 6 (25) : 21268 - 21282
  • [22] Co-targeting EGFR and IKKβ/NF-κB signalling pathways in head and neck squamous cell carcinoma: a potential novel therapy for head and neck squamous cell cancer
    Zhipeng Li
    Jipei Liao
    Zejia Yang
    Eun Yong Choi
    Rena G. Lapidus
    Xuefeng Liu
    Kevin J. Cullen
    Hancai Dan
    British Journal of Cancer, 2019, 120 : 306 - 316
  • [23] Co-targeting EGFR and IKKβ/NF-κB signalling pathways in head and neck squamous cell carcinoma: a potential novel therapy for head and neck squamous cell cancer
    Li, Zhipeng
    Liao, Jipei
    Yang, Zejia
    Choi, Eun Yong
    Lapidus, Rena G.
    Liu, Xuefeng
    Cullen, Kevin J.
    Dan, Hancai
    BRITISH JOURNAL OF CANCER, 2019, 120 (03) : 306 - 316
  • [24] INTERFERON INHIBITS THE INVITRO GROWTH OF HUMAN HEAD AND NECK SQUAMOUS CARCINOMA CELL-LINES
    LESTER, EP
    CLINICAL RESEARCH, 1990, 38 (04): : A946 - A946
  • [25] (-)-Gossypol inhibits growth and promotes apoptosis of human head and neck squamous cell carcinoma in vivo
    Wolter, Keith G.
    Wang, Steven J.
    Henson, Bradley S.
    Wang, Shaomeng
    Griffith, Kent A.
    Kumar, Bhavna
    Chen, Jianyong
    Carey, Thomas E.
    Bradford, Carol R.
    D'Silva, Nisha J.
    NEOPLASIA, 2006, 8 (03): : 163 - 172
  • [26] Sulindac induces apoptosis and inhibits tumor growth in vivo in head and neck squamous cell carcinoma
    Scheper, Mark A.
    Nikitakis, Nikolaos G.
    Chaisuparat, Risa
    Montaner, Silvia
    Sauk, John J.
    NEOPLASIA, 2007, 9 (03): : 192 - 199
  • [27] Effect of bortezomib on EGFR expression in head and neck squamous cell carcinoma cell lines
    Wagenblast, Jens
    Hambek, Markus
    Baghi, Mehran
    Knecht, Rainald
    ANTICANCER RESEARCH, 2008, 28 (2A) : 687 - 692
  • [28] Involvement of EGFR in the response of squamous cell carcinoma of the head and neck cell lines to gefitinib
    Taguchi, Takahide
    Tsukuda, Mamoru
    Imagawa-Ishiguro, Yukari
    Kato, Yasumasa
    Sano, Daisuke
    ONCOLOGY REPORTS, 2008, 19 (01) : 65 - 71
  • [29] Understanding c-MET signalling in squamous cell carcinoma of the head & neck
    Szturz, P.
    Raymond, E.
    Abitbol, C.
    Albert, S.
    De Gramont, A.
    Faivre, S.
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2017, 111 : 39 - 51
  • [30] Predictive biomarkers and EGFR inhibitors in squamous cell carcinoma of head and neck (SCCHN)
    Vigneswara, V.
    Kong, A.
    ANNALS OF ONCOLOGY, 2018, 29 (04) : 794 - 796
12345